Activin-A is increasingly recognized as a potential therapeutic agent for conditions such as brain injury and inflammatory diseases. Studies have shown that it can help reduce damage and inflammation, ...

KACTUS, a leading recombinant protein manufacturer, has published a technical framework for engineering 2+1 and trispecific T-cell engager (TCE) therapeutics.

In pharmaceutical research and development as well as basic scientific research, recombinant proteins serve not only as essential research tools but also as potential therapeutic agents or key factors ...

Nuclera (Cambridge, UK) is a biotech company that specializes in rapid protein expression and purification optimization at the benchtop. With the aim of streamlining the drug discovery process, ...

Discover how arbovirus E Dimer vaccines are engineered to improve safety by minimizing antibody dependent enhancement.

Validated across diverse cell lines and molecule formats, switching to UltraFeed as the fed-batch supplement has enabled titers reaching 10g/L, with peak VCD increases up to 20% and harvest viability ...

A blood test looks simple – needle in, blood out. The vial is ready. Same with a vaccine. But, between the simple in and out, ...